Arrhythmia Detection is Improved by 14-Day Continuous Electrocardiography Patch Monitoring and CHA2DS2-VASc Score

Background: Arrhythmias are not always easy to capture because they are often paroxysmal or asymptomatic. Methods: Using the CHA2DS2-VASc score for arrhythmia risk assessment, a 14-day electrocardiography monitor patch was used to evaluate patients with no documented history of arrhythmia. Results: Ninety-three patients (mean age 59.8 ± 12.0 years, 46.2% female) received 14-day electrocardiography telemonitoring, and 14 patients (15%) were diagnosed with arrhythmias during a follow-up of 1004.4 person-days (meanrecordeddays10.8± 4.1). The patients who were detected to have arrhythmias were older and had a higher prevalence of heart failure and chronic kidney disease. The result showed that arrhythmias were more likely to develop during a 14-day monitoring period in the patients with a CHA2DS2-VASc score of ≥ 3or≥ 4. Atrioventricular block was more likely to be detected in the patients with a CHA2DS2-VASc score of ≥ 3or≥ 4 during 7-day or 14-day monitoring periods. Ventricular tachycardia was also more likely to be detected in the patients with a CHA2DS2VASc score of ≥ 4or≥ 5 during a 14-day monitoring period. When evaluating the risk of arrhythmia, a CHA2DS2VASc score of ≥ 3or≥ 4 was associated with a higher risk of any arrhythmias during a 14-day monitoring period, whileaCHA2DS2-VAScscoreof≥ 4 was associated with a higher risk of any arrhythmias during a 7-day monitoring period. Conclusions: The results may suggest that a 14-day monitoring period is more favorable to detect arrhythmias. Atrioventricular block and ventricular tachycardia were more likely to develop in the patients with a higher CHA2DS2-VASc score.